Drug intelligence / Profile preview

sophocarpine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intravenous, Intraperitoneal, Transdermal
01

Overview

Sophocarpine is a tetracyclic quinazoline alkaloid derived from the foxtail-like sophora herb (*Sophora alopecuroides* L.) and its seeds. It possesses a broad range of pharmacological properties, including anti-tumor, anti-inflammatory, antioxidant, and antifibrotic effects. In preclinical oncology research, sophocarpine has demonstrated the ability to inhibit the progression of glioblastoma multiforme (GBM) by upregulating the tumor suppressor PTEN and subsequently downregulating the PI3K/Akt signaling pathway, leading to cell cycle arrest and apoptosis. In metabolic studies, it has shown efficacy in alleviating hepatocyte steatosis in models of non-alcoholic steatohepatitis (NASH) by activating the AMPK signaling pathway and modulating adipocytokine synthesis. Furthermore, sophocarpine is being investigated for the treatment of pulmonary hypertension (PH), where it appears to reduce pulmonary artery pressure and inflammatory responses while restoring the balance of pulmonary artery remodeling.

Other names
sophocarpine
02

Targets

AKT (RAC-alpha serine/threonine-protein kinase)AMPK (Adenosine monophosphate–activated protein kinase)HMOX1 (Heme oxygenase 1)MAPK3 (Mitogen-activated protein kinase 1)NFKB1 (NF-κB1)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)TLR4 (Toll-like receptor 4)HNF4A (Hepatocyte nuclear factor 4 alpha)SREBP-1 / SREBF1 (SREBP-1)

Beyond the preview

Go deeper on sophocarpine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sophocarpine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call